Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial140
CAR T-cell therapy comes of age: Introductory editorial for the special issue60
Clinical applications of circulating tumor DNA in Hodgkin lymphoma40
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies33
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia31
Evolving Insights into Mitochondrial Presence in RBC in Sickle Cell Disease: Red Blood Cell and Reticulocyte Pathophysiology, Therapeutic Strategies, and Future Directions29
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation28
Updates on current and future research in acute myeloid leukemia27
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1922
How to set up a clinical research center in Brazil, as an example of a middle-income country21
Epidemiology and etiology of diffuse large B-cell lymphoma20
Somatic mutations in “benign” blood diseases19
Lessons learned from the Eµ-TCL1 mouse model of CLL19
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence18
Antibody and immunotherapy in diffuse large B-cell lymphoma17
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services17
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?16
TET2 mutation as prototypic clonal hematopoiesis lesion16
0.042741060256958